INCRUSE ELLIPTA Reviews (UMECLIDINIUM BROMIDE)

Average Rating: 1.8 (17 Ratings)

Filter Results

Compare INCRUSE ELLIPTA with similar:

 Type: Rx Drug

  

INCRUSE ELLIPTA  (UMECLIDINIUM BROMIDE):  Umeclidinium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes bronchitis and emphysema). It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.   FDA Approval Date: 2014-04-30 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


More on INCRUSE ELLIPTA: Reviews Summary  |  Drug Safety Information

RATING  REASONSIDE EFFECTS FOR INCRUSE ELLIPTACOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 4  Shortness of breath No side effects The results are noticeable after long time use. My second spirometry test (2 months apart) noticed a significant increase in my lung capacity. And I noticed it also. But I didn’t notice much increase in the first month. M 71 2 months
1X day
2/16/2023
 1  Bronchiectasis Seem to be loosing more hair than normal and no improvement whatsoever with breathing F 76 23 days
1 puff per 1X day
2/22/2022
Email
 1  COPD Makes my chest feel heavy and hard to breathe. F 66 2 months
62.5MG 1X day
3/25/2021
 2  Mild copd Wasn't having symptoms in the first place except for some wheezing occasionally. Tastes terrible. I don't think I will continue this med. I don't feel it's necessary and why put this in my body if it's not needed? F 64 14 days
1X day
12/16/2020
 1  Was given by respiratory nurse Terrible sore and dry throat constantly coughing have stopped using it and throat has begun heal I manage with my symbicort200/6 and reliever F 72 40 days
55 1X day
10/22/2020
 1  Mild emphysema It does not help my shortness of breath. It is worse. My nose is dry but stuffy and bloody when I blow it. My tongue and mouth are very dry. F 68 11 days
62.5 mcg 1X day
9/22/2020
 1  Copd Coughing spells for about 20 minutes after taking it. F 62 7 days
62.5
6/17/2020
 4  Asthma It worked great as far as breathing, but it had a severe drying effect on my lips and mouth. I had blisters in my mouth and splits on my lips. It also looked like I have a SEVERE CASE of chapped/windburned lips. No amount of medicated chapstick or lips balm helped!! I have to choose between breathing and having so much pain i can hardly eat or drink!? Really unfair! F 47 1 months
5/21/2020
Email
 1  COPD First the powder made my mouth numb... I took it once and felt like I was having a difficult time breathing so I didn't take it again. Ever since my chest has been tight and I'm having panic attacks. I was just diagnosed with COPD and never had symptoms or problems breathing until taking this. F 39 2 days
3/28/2020
Email
 1  spiriva dropped by insurance I have been on spiriva for years and it works well for me. Blue cross/blue shield stopped paying for it so I was given Incruse. I have been so sick ever since. Non-stop coughing, sneezing, very tight lungs, hard to get air out, stuffy nose, not sleeping because of the coughing. It all started less than a week after starting Incruse. F 48 1 days
1/30/2020
Email
 4  COPD, Emphysema Muscle pain F 74 18 months
62.5
11/6/2019
 3  Asthma Makes me feel like I'm going to have a seizure. Don't feel safe to drive. I think this is a very bad drug. Going to tell my dr. To get me off of this med. Felt better on spriva but became allergic to it. F 60 7 days
62.5
3/18/2019
 1  pulmonologist prescribed for COPD No side effects I never could tell any difference but kept taking it to follow doctor's instructions. I can't tell any difference--good or bad--so I'm going to quit taking it and see what happens. I wasn't having severe symptoms in the first place. M 67 1 years
62.5 mcg d
1/14/2019
Email
 1  copd Does not help. The delivery system is not good. The powder goes in my mouth not down into my lungs. Has not helped my breathing. I was using Spiriva until Medicare cut if off and it worked well. Incruse ellipta is a. very Poor substitute. F 66 2 weeks
62.5 1X day
6/5/2018
 1  COPD Breathing is worse on Incruse Ellipta. Shortness of breath, tightness in chest, thick mucous. Spiriva wasn't working, so I switched to Incruse. It's just as worthless as Spiriva. I'll just use my Proair (Albuterol) 2x per day. F 67 2 weeks
3/12/2018
 1  Copd Shortness of breath became worse I also had asthma attack even though I was taking symbicort as well it just doesn't suit me F 69 7 days
62.5 mcg
9/26/2017
 3  Shortness of breath So far just headaches. Works better than some of the other meds in its class. M 36 3 weeks
62.5 MCG
4/1/2016
  

INCRUSE ELLIPTA  (UMECLIDINIUM BROMIDE):  Umeclidinium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes bronchitis and emphysema). It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.   FDA Approval Date: 2014-04-30 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP